0001570562-24-000090.txt : 20240515
0001570562-24-000090.hdr.sgml : 20240515
20240515172008
ACCESSION NUMBER: 0001570562-24-000090
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240513
FILED AS OF DATE: 20240515
DATE AS OF CHANGE: 20240515
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GILL DAVID N
CENTRAL INDEX KEY: 0001106519
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38381
FILM NUMBER: 24952616
MAIL ADDRESS:
STREET 1: C/O NXSTAGE MEDICAL INC. (NXTM)
STREET 2: 439 SOUTH UNION STREET, 5TH FLOOR
CITY: LAWRENCE
STATE: MA
ZIP: 01843
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Evolus, Inc.
CENTRAL INDEX KEY: 0001570562
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 461385614
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 520 NEWPORT CENTER DRIVE
STREET 2: SUITE 1200
CITY: NEWPORT BEACH
STATE: CA
ZIP: 92660
BUSINESS PHONE: (949) 284-4555
MAIL ADDRESS:
STREET 1: 520 NEWPORT CENTER DRIVE
STREET 2: SUITE 1200
CITY: NEWPORT BEACH
STATE: CA
ZIP: 92660
4
1
wk-form4_1715807991.xml
FORM 4
X0508
4
2024-05-13
0
0001570562
Evolus, Inc.
EOLS
0001106519
GILL DAVID N
520 NEWPORT CENTER DR.
SUITE 1200
NEWPORT BEACH
CA
92660
1
0
0
0
0
Common Stock
2024-05-13
4
S
0
3643
12.7247
D
40682
D
Common Stock
2024-05-14
4
S
0
6718
12.601
D
33964
D
The shares were sold in multiple trades at prices ranging from $12.72 to $12.74. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The shares were sold in multiple trades at prices ranging from $12.60 to $12.61. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
/s/ Jeffrey J. Plumer, as attorney-in-fact for David N. Gill
2024-05-15